ライフサイエンスコーパス: infectious disease

1 ecialties (73.1% for psychiatry to 87.8% for infectious disease).

2 r-mediated immune responses to virtually any infectious disease.

3 exity and dimensionality, for a measles-like infectious disease.

4 needed attention to the effects of amphibian infectious disease.

5 unexpected and important concepts underlying infectious disease.

6 he leading cause of birth defects related to infectious disease.

7 surgery, cardiac pathology, immunology, and infectious disease.

8 s the leading cause of death due to a single infectious disease.

9 evant in the age global change-induced human infectious disease.

10 ility of host populations to sustain endemic infectious disease.

11 signs have been used to monitor the onset of infectious disease.

12 important for understanding biodiversity and infectious disease.

13 ailable shortly after the emergence of a new infectious disease.

14 preferred method for rapid diagnosis of many infectious diseases.

15 the society by reducing the transmission of infectious diseases.

16 aid in reducing the incidence and spread of infectious diseases.

17 stics are essential to control the spread of infectious diseases.

18 present the future trend in the diagnosis of infectious diseases.

19 in expanding checkpoint inhibitor therapy in infectious diseases.

20 the diagnosis, monitoring, and treatment of infectious diseases.

21 issue, especially with outbreaks of emerging infectious diseases.

22 o phenotypic variation such as resistance to infectious diseases.

23 gislation that will maximize the response to infectious diseases.

24 es have become an important tool in treating infectious diseases.

25 response to illicit drug use and associated infectious diseases.

26 used for primary prophylaxis in a number of infectious diseases.

27 etrics via simulations and an application in infectious diseases.

28 sulting in increased susceptibility to other infectious diseases.

29 ies, patient outcomes, and the management of infectious diseases.

30 We examined if rTM might worsen infectious diseases.

31 become widespread in many fields, including infectious diseases.

32 an important animal model for AIDS and other infectious diseases.

33 munities that are associated with many human infectious diseases.

34 be exploited to improve the control of some infectious diseases.

35 US National Institute of Allergy and Infectious Diseases.

36 and, eventually, support the elimination of infectious diseases.

37 even preventing the spread of such emerging infectious diseases.

38 thought to provide protection against non-TB infectious diseases.

39 l protection against multiple mosquito-borne infectious diseases.

40 ost effective means available for preventing infectious diseases.

41 blood-feeding behavior in a deadly vector of infectious diseases.

42 the time to treatment, especially in case of infectious diseases.

43 diseases (PIDD) and for prophylaxis against infectious diseases.

44 e of stress, exemplified through the risk of infectious diseases.

45 logical dynamics of established and emerging infectious diseases.

46 ly warning systems for the (re-)emergence of infectious diseases.

47 nd other interventions to decrease spread of infectious diseases.

48 essary to improve the clinical management of infectious diseases.

49 d future preparedness for COVID-19 and other infectious diseases.

50 testinal biology, including inflammatory and infectious diseases.

51 6 experts in the fields of health policy and infectious diseases.

52 during homeostasis, tissue development, and infectious diseases.

53 and treatment of cancers, cardiovascular and infectious diseases.

54 cterization of behavioral changes induced by infectious diseases.

55 makes this species especially vulnerable to infectious diseases.

56 inclusion, diversity, access, and equity in infectious diseases.

57 caffolds as a source of therapeutics against infectious diseases.

58 opment and National Institute of Allergy and Infectious Diseases.

59 ling could be used to increase resistance to infectious diseases.

60 ies to target microorganisms responsible for infectious diseases.

61 rantly regulated in several inflammatory and infectious diseases.

62 id and inexpensive diagnostics of cancer and infectious diseases.

63 microorganisms, and host protection against infectious diseases(1,2).

64 Coronavirus infectious disease 2019 (COVID-19) pandemic has posed at

65 provide further perspectives on coronavirus infectious disease 2019 (COVID-19), as well as draw infe

66 ntial to the broader response to coronavirus infectious disease 2019 (COVID-19), including epidemiolo

67 es the tissue susceptibility for coronavirus infectious disease 2019 infection.

68 on that postoutbreak recovery-which involves infectious disease, a biological hazard-presents challen

69 African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede

70 hich do not require advanced technology (eg, infectious diseases, addictions), can eventually lead to

71 tic benefit of monoclonal antibodies against infectious disease agents may be debatable, the function

72 their potential in three therapeutic areas: infectious disease, Alzheimer's disease, and cancer.

73 nservation efforts to mitigate the impact of infectious diseases, an increasingly recognized cause of

74 My objective was to analyze recent trials in infectious disease and consider needs for future trials.

75 ct of anthropogenic nutrient supply rates on infectious disease and feedbacks to ecosystem carbon and

76 ms more human lives than any other bacterial infectious disease and represents a clear and present da

77 vidual benefit of protecting recipients from infectious diseases and also the indirect social benefit

78 that is widely used to develop vaccines for infectious diseases and cancer.

79 included specialists in pulmonary medicine, infectious diseases and clinical microbiology, laborator

80 al trends in emerging nanoscale vaccines for infectious diseases and describes the biological, experi

81 , investigations into host susceptibility to infectious diseases and downstream sequelae have never b

82 e detection of various pathogens involved in infectious diseases and food contamination.

83 rstanding of microbial species, metagenomes, infectious diseases and more.

84 US National Institute of Allergy and Infectious Diseases and National Cancer Institute, Natio

85 US National Institute of Allergy and Infectious Diseases and National Cancer Institute.

86 e powerful tools to develop immune memory to infectious diseases and prevent excess mortality.

87 pulmonary disease, including specialists in infectious diseases and pulmonary diseases.

88 ed prevention and treatment services for the infectious diseases and substance use disorder care cont

89 status of immune cell therapies for cancer, infectious disease, and autoimmunity, and discuss advanc

90 fields of tick biology, allergy, immunology, infectious disease, and dermatology discussed the curren

91 by the need for better therapies for cancer, infectious diseases, and autoimmune disorders.

92 targets to treat autoinflammatory disorders, infectious diseases, and cancer.

93 tact tracing is used to control outbreaks of infectious diseases, and has been used for coronavirus d

94 e processes including embryonic development, infectious diseases, and myelosuppressive injuries cause

95 rch at the National Institute of Allergy and Infectious Diseases, and National Institutes of Health.

96 during the pandemic, the role of transplant infectious diseases, and the influence of transplant soc

97 iseases-notably autoimmune, inflammatory and infectious diseases-and identifying potential therapeuti

98 systems biology approaches for the study of infectious disease are quickly forming a new paradigm fo

99 Infectious diseases are a major cause of morbidity and m

100 for shrimp-related pathogens remain unclear, infectious diseases are difficult to prevent and control

101 in QCM-based biosensors for the detection of infectious diseases are extensively reviewed, with a foc

102 Because infectious diseases are implicated in pollinator decline

103 ss mortality events associated with emerging infectious diseases are often associated with high numbe

104 Emerging infectious diseases are responsible for declines in wild

105 Many infectious diseases are thought to have emerged in human

106 Infectious diseases as a specialty is tilted toward soci

107 tive against a number of important childhood infectious diseases as well as poor growth outcomes, wit

108 for the development of rapid diagnostics for infectious diseases because they have high sensitivity,

109 ory, growth-promoting macrophages in a human infectious disease, biopsies from patients with leprosy

110 otential to broaden our understanding of the infectious disease burden common to past populations fro

111 (TB) is a leading cause of mortality due to infectious disease, but the factors determining disease

112 ing potential to not only be used to monitor infectious diseases, but also to inform control policies

113 ency is associated with non-communicable and infectious diseases, but the vitamin D status of African

114 omized trials for studying interventions for infectious diseases, but we also anticipate the method t

115 e in eradicating or mitigating the spread of infectious diseases by bolstering our immunity.

116 impact the spatial transmission dynamics of infectious diseases by introducing pathogens into suscep

117 ists targeting nucleic acid sensors to treat infectious disease, cancer, and autoimmune and inflammat

118 n the efficacy of antibiotics and quality of infectious diseases care in critical care settings.

119 Some infectious diseases cause an increased risk of developin

120 virus disease 2019 (COVID-19) is an emerging infectious disease caused by a novel coronavirus (SARS-C

121 Diphtheria is an infectious disease caused by Corynebacterium diphtheriae

122 threatens effective treatment of malaria, an infectious disease caused by Plasmodium parasites.

123 navirus disease 19 (COVID-19) is an emerging infectious disease caused by SARS-CoV-2.

124 Tuberculosis is an infectious disease caused by the bacterium Mycobacterium

125 COVID-19 is an infectious disease caused by the coronavirus SARS-CoV-2,

126 Tuberculosis, a severe infectious disease caused by the Mycobacterium tuberculo

127 Scrub typhus, a neglected infectious disease caused by the obligate intracellular

128 Infectious diseases caused by pathogenic bacteria, espec

129 Vaccines save millions of lives from infectious diseases caused by viruses and bacteria.

130 Coronavirus disease 2019 (COVID-19) is an infectious disease, caused by severe acute respiratory s

131 Malaria remains one of the most deadly infectious diseases, causing hundreds of thousands of de

132 hange is expected to have complex effects on infectious diseases, causing some to increase, others to

133 gn of Ab-related therapies in the context of infectious diseases, chronic inflammation, and cancer.

134 these peptides to develop new therapies for infectious diseases, chronic inflammatory disorders and

135 IDSA convened a multidisciplinary panel of infectious diseases clinicians, clinical microbiologists

136 A multidisciplinary panel of infectious diseases clinicians, clinical microbiologists

137 the use of high-flow oxygen, engagement with infectious disease consultants, and cardiac arrest.

138 organisms (45%), cautious interpretation and infectious diseases consultation are prudent.

139 between 01/2016 and 07/2019, who received an infectious diseases consultation for an invasive bacteri

140 CLSI suggests infectious diseases consultation to guide daptomycin use

141 As new infectious diseases continue to emerge, together with gr

142 COVID-19 patients admitted to the Infectious Diseases department of a tertiary level Swedi

143 and shotgun-based metagenomics approaches to infectious disease diagnostic methods.

144 2018, the National Institute of Allergy and Infectious Diseases, Division of Allergy, Immunology and

145 Forecasting the spatiotemporal spread of infectious diseases during an outbreak is an important c

146 ate and climate change on wildlife and human infectious disease dynamics over the past several years.

147 Emerging infectious diseases (EIDs) of plants continue to devasta

148 arying prognostic for the growth rate of any infectious disease epidemic.

149 In infectious disease epidemiology, this coefficient is rel

150 on, highlighting the importance of including infectious disease epizootics in studies of behavioural

151 uropean Society of Clinical Microbiology and Infectious Diseases (ESCMID), Swedish, and Dutch guideli

152 learly a complex multifactorial disorder, an infectious disease etiology provides alternative therapy

153 National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Ins

154 edictive of the subsequent development of an infectious disease event or mortality over the 12 month

155 Physicians and nurses who had no infectious disease expertise were recruited to provide c

156 Three alumni matriculated to accredited US infectious diseases fellowships.

157 s with clinical potential in response to new infectious diseases for which no specific drugs or vacci

158 The consensus definitions of the Infectious Diseases Group of the European Organization f

159 erstanding of spatiotemporal transmission of infectious diseases has improved significantly in recent

160 Emerging infectious diseases have caused many species declines, c

161 Infectious diseases have the potential to exacerbate the

162 eases in injection drug use (IDU)-associated infectious diseases; however, little is known about how

163 dback (PPRF) in November 2015 with mandatory infectious disease (ID) consultation for all meropenem a

164 review our experience of providing inpatient infectious disease (ID) consultations using real-time in

165 To determine the impact of these trends, infectious disease (ID) physicians were surveyed regardi

166 and 2 times weekly at the 176-bed hospital, infectious diseases (ID) physicians remotely reviewed pa

167 ortality (stunting-related deaths from other infectious diseases) identified high-risk areas that cou

168 opting this approach limits understanding of infectious disease impacts and hampers conservation effo

169 mastitis is the most economically important infectious disease in dairy industry, and Escherichia co

170 potential to become a point-of-care test for infectious disease in public health and clinical setting

171 framework for a systems biology approach to infectious disease in three parts: discovery - the desig

172 to reduce overdose deaths and the spread of infectious disease in vulnerable populations.

173 Fighting Infectious Diseases in Emerging Countries and Bill & Mel

174 paper reviews (1) programs most relevant to infectious diseases in the 2018 SUPPORT Act; (2) opportu

175 body therapy to limit inflammation for other infectious diseases in which inflammatory damage plays a

176 tric hematology/oncology and HSCT, pediatric infectious diseases (including antibiotic stewardship),

177 inating DENV IgG against antibodies of other infectious disease, including the closely related Zika v

178 postexposure prophylaxis and/or treatment of infectious diseases, including other outbreaks of corona

179 Infectious disease-induced MMEs (ID MMEs) have not been

180 We conducted a cross-sectional study at the Infectious Diseases Institute, Kampala, Uganda.

181 Risk of infectious disease is increased among individuals with C

182 at our current approach to emerging zoonotic infectious disease is ineffective.

183 Increased mortality rates from infectious diseases is a growing public health concern.

184 anticipating the emergence or reemergence of infectious diseases is both important and timely; howeve

185 Susceptibility to infectious diseases is determined by a complex interacti

186 health crises because the emergence of novel infectious diseases is partially driven by global enviro

187 Tuberculosis (TB), one of the deadliest infectious diseases, is caused by Mycobacterium tubercul

188 consulted for diagnosis and treatment of the infectious disease, it is clear that successful manageme

189 National Institute of Allergy and Infectious Diseases, Johns Hopkins Health System, and U.

190 For B. anthracis and most other infectious diseases, knowledge regarding transmission an

191 Infectious diseases like tuberculosis (TB) and HIV are e

192 By contrast, for some infectious diseases, managing particular species or habi

193 ral systems is accelerating the emergence of infectious diseases, mandating integration of disease an

194 In diagnostics of infectious diseases, matrix-assisted laser desorption/io

195 ed considerable concern in the international infectious disease, medical microbiology, and public hea

196 We reviewed 5 studies that used infectious disease modeling to assess the potential impa

197 are still associated with increased rates of infectious disease mortality such that an increase in PC

198 id corresponds with a 5% increase in risk of infectious disease mortality.

199 ogical thresholds and indices of health like infectious disease mortality.

200 s (MuV) is the causative agent of the highly infectious disease mumps.

201 National Institute of Allergy and Infectious Diseases, National Institute on Drug Abuse, N

202 In exploring the epidemiology of infectious diseases, networks have been used to reconstr

203 tion), the National Institute of Allergy and Infectious Diseases (NIAID), the European Union, the Ber

204 contract; National Institute for Allergy and Infectious Diseases, NIH, to the I4C Martin Delaney Coll

205 es from Western Kenya which were part of the Infectious Disease of East African Livestock (IDEAL) coh

206 sk of autoimmune, metabolic, neoplastic, and infectious diseases of the intestine and mitigate the pa

207 is critical for understanding the effects of infectious diseases on wildlife populations.

208 Infectious disease outbreaks emerged across the globe du

209 about the care of these children, suggesting infectious disease outbreaks in these detainment centers

210 design and analysis of these studies during infectious disease outbreaks is complicated by statistic

211 to drive complex, nonlinear dynamics during infectious disease outbreaks.

212 lth and well-being, including an increase in infectious disease outbreaks.

213 nical needs of patients affected by emerging infectious disease outbreaks.

214 nd healthcare can increase susceptibility to infectious diseases, particularly among children.

215 According to the present view on infectious diseases pathogen resistance is linked to hum

216 atory response, immune cell trafficking, and infectious disease pathways.

217 t surgery, transplant psychiatry, transplant infectious disease, pharmacy, and endocrinology were con

218 Applied to an infectious disease phylodynamic dataset of sequences fro

219 Shortcomings in the current pipeline of infectious disease physician scientists are well documen

220 luding ophthalmologists, pulmonologists, and infectious disease physicians) generated preliminary con

221 ant infections were identified by transplant-infectious diseases physicians in persons receiving soli

222 ls can be used to inform domestic and global infectious diseases policies to improve healthcare syste

223 Emerging infectious diseases pose one of the greatest threats to

224 Standard infectious disease practice calls for aggressive drug tr

225 formation that bears on this emerging global infectious disease problem.

226 It can also contribute to infectious disease progression.

227 Metagenomic next-generation sequencing for infectious diseases promises an unbiased approach to det

228 object (e.g., a pathogen [in the context of infectious disease propagation] or a piece of informatio

229 t strategies, particularly in the setting of infectious diseases, provide consensus recommendations f

230 donor evaluation process, explain where the infectious diseases provider fits in this scheme, and de

231 926-2019), National Institute of Allergy and Infectious Disease (R21 AI145356, R21 AI152318, and AI15

232 WID) are needed for monitoring risk-specific infectious disease rates and health services coverage.

233 oplasia rates as low as 3.1% and 1.8%, while infectious-disease rates were 32.0% and 53.9% in extant

234 Fungal infections are a major contributor to infectious disease-related deaths across the globe.

235 Infectious diseases remain a constant threat on a global

236 The transmission of some infectious diseases requires that pathogens can survive

237 year, billions of US$ are spent globally on infectious disease research and development.

238 neral increase in year-on-year investment in infectious disease research between 2000 and 2006, with

239 search awards made between 2000 and 2017 for infectious disease research from G20-based public and ph

240 d animals on large scale farms, little to no infectious disease research is conducted at this interfa

241 ly been used in a vast array of analyses for infectious disease research of public health relevance.

242 l 2000-17 dataset included 94 074 awards for infectious disease research, with a sum investment of $1

243 pports the National Institute of Allergy and Infectious Diseases research agenda.

244 dentified a separation of bat ecologists and infectious disease researchers with few cross-disciplina

245 eases; the National Institute of Allergy and Infectious Diseases; Rheumatology Research Foundation In

246 on whether biodiversity reduces or increases infectious disease risk, a question that directly affect

247 ct where environmental change may most alter infectious disease risk.

248 tial drivers of immunity could help pre-empt infectious disease risks, especially in the context of h

249 g struggle with new, re-emerging and endemic infectious diseases serves as a frequent reminder of the

250 ading international respiratory medicine and infectious diseases societies (ATS, ERS, ESCMID, IDSA) a

251 work-related barriers to advancement to the Infectious Disease Society of America (IDSA) membership.

252 adherence to the recommendations made in the Infectious Disease Society of America (IDSA), European S

253 pathways to leadership positions within the Infectious Diseases Society of America (IDSA) are expand

254 The American Thoracic Society (ATS) / Infectious Diseases Society of America (IDSA) Community-

255 The Infectious Diseases Society of America (IDSA) convened a

256 We provide evidence to revise the Infectious Diseases Society of America (IDSA) diabetic f

257 In 2018, the Infectious Diseases Society of America (IDSA) published

258 Thus, the Infectious Diseases Society of America (IDSA) recognized

259 Adherence to Infectious Diseases Society of America (IDSA) recommenda

260 Following the establishment of the Infectious Diseases Society of America (IDSA), women pla

261 rred azole for histoplasmosis in the current Infectious Diseases Society of America guidelines.

262 panel of the HIV Medicine Association of the Infectious Diseases Society of America updates previous

263 ridiodes difficile infection (CDI), the 2017 Infectious Diseases Society of America-Society for Healt

264 nd Prevention, European Respiratory Society, Infectious Diseases Society of America.

265 Alert, for rapid evaluation supported by an infectious disease specialist.

266 c diseases such as hypertension and emerging infectious diseases such as coronavirus disease 2019 (CO

267 results from the few CAR T-cell studies for infectious diseases such as HIV-1 have been less convinc

268 For many life-threatening global infectious diseases, such as human immunodeficiency viru

269 c tests are first-line assays for diagnosing infectious diseases, such as malaria.

270 rgence and transcontinental spread of fungal infectious diseases, such as pandrug-resistant Candida a

271 ostics is essential in managing outbreaks of infectious diseases, such as the pandemic of coronavirus

272 shone a bright light on the weaknesses in US infectious disease surveillance and a broader gap in our

273 ghlight the importance of the host genome in infectious disease susceptibility and severity and offer

274 is having profound effects on the ecology of infectious disease systems, which are widely anticipated

275 d, as a result, some are more susceptible to infectious disease than others.

276 Malaria is an infectious disease that affects over 216 million people

277 affecting chickens, and remains as a chronic infectious disease that threatens the poultry industry.

278 kin structure infections (ABSSSI) are common infectious diseases that cause a significant economic bu

279 arizes a set of recent, innovative trials in infectious diseases that redefine previous, non-evidence

280 With the increasing spread of many infectious diseases, the emergence of a vicious climate-

281 ation, the National Institute of Allergy and Infectious Diseases, the National Institute of Mental He

282 For infectious diseases, the steady rise of antibiotic resis

283 ch of the National Institute for Allergy and Infectious Diseases, the World Bank, the Doris Duke Char

284 ors could lay the foundation for alternative infectious disease therapy using available therapeutic a

285 erwhelming success of vaccines in preventing infectious diseases, there remain numerous globally deva

286 mate changes are thought to promote emerging infectious diseases, though to date, evidence linking cl

287 nse, the relevance of these applications for infectious disease transmission and control, and potenti

288 inferences of bacterial strain diversity and infectious disease transmission studies largely assume a

289 alidating SNPs and other factors controlling infectious disease transmission.

290 tailed spatial data to interrupt and control infectious disease transmission.

291 th programs, particularly those that involve infectious disease transmission.

292 nfectee pair, is commonly used to understand infectious diseases transmission.

293 The noninferiority trial design and recent infectious disease trials of relevance are discussed in

294 s a first-line therapeutic used to treat the infectious disease tuberculosis (TB), which is caused by

295 tion Framework; and vulnerability, using the Infectious Disease Vulnerability Index.

296 uld be a key to the metagenomic diagnosis of infectious diseases when a microbe is visualized but rem

297 understanding how to mitigate the spread of infectious diseases within human and wildlife hosts.

298 Tuberculosis (TB) remains a major infectious disease worldwide.

299 Malaria is one of the most life-threatening infectious diseases worldwide, caused by infection of hu

300 ins among the most common complications from infectious diseases worldwide.